Standard BioTools Standard BioTools Q1 Revenues Fall 19 Percent In Q1 the company formerly known as Fluidigm completed a strategic evaluation process and closed a $250 million capital infusion from Casdin Capital and Viking Global Investors. Fluidigm Obtains $250M Investment, Changing Name to Standard BioTools The firm intends to simplify the design and execution of deep cell profiling, and standardize sample analysis with reproducible workflows and automation. Breaking News People in the News at Genomill, Oxford Nanopore, Myriad Genetics, More Single-Cell Analysis of Colorectal Cancer Uncovers Two Epithelial-Cell Based Subtypes New Products Posted to GenomeWeb: Bio-Rad, Beckman Coulter, Oncologica, More In Brief This Week: Pacific Biosciences, Invitae, Grail, Mainz Biomed, Molzym, More GenomeWeb Top 40 Down 5 Percent in June, Tracking Broader Market Decline The Scan Pig Organ Transplants Considered The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans. 'Poo-Bank' Proposal Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases. Spurred to Develop Again New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing. Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.